位置：成果数据库 > 期刊 > 期刊详情页
Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer:
  • ISSN号：0008-5472
  • 期刊名称：Cancer Research
  • 时间：2012.1.1
  • 页码：408-419
  • 相关项目：揭示微环境中趋化因子Decoy受体的功能性基因多态对乳腺癌转移潜能的影响
作者： Yu, Ke-Da|Huang, A-Ji|Fan, Lei|Li, Wen-Feng|Shao, Zhi-Ming|
同期刊论文项目
揭示微环境中趋化因子Decoy受体的功能性基因多态对乳腺癌转移潜能的影响
期刊论文 21
同项目期刊论文
Immediate postmastectomy breast reconstruction showed limited advantage in patient survival after st
Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic pote
Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survi
Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressi
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breas
Effect of large tumor size on cancer-specific mortality in node-negative breast cancer.
Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer.
ESR1 gene amplification: another mechanism regulating the cellular levels of ERalpha.
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast canc
Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer
The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer ris
Inspection of a deviation from Hardy-Weinberg equilibrium in familial breast cancer cases from a cas
The two faces of autophagy and the pathological underestimation of DCIS.
Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased d
Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer
Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS wit
Polymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HE
Gene variations associated with drug resistance in breast cancer